The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project
MECA
Impact of Technology-based Intervention for Improving Self-management Behaviors in Black Adults With Poor Cardiovascular Health: MECA Clinical Intervention Project
1 other identifier
interventional
150
1 country
3
Brief Summary
This study will recruit from participants in the Morehouse-Emory Cardiovascular (MECA) study for a clinical intervention examining cardiac outcomes between participants who are randomized to received Health360x (a web-based and mobile-based application) or Health360x plus personalized health coaching. Participants will receive instruction on using the Health360x application and will use Health360x alone or Health360x with a health coach for 6 months. Measures of cardiovascular health will be assessed at baseline and after the 6 month long intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cardiovascular-diseases
Started Jul 2017
Typical duration for not_applicable cardiovascular-diseases
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2017
CompletedFirst Submitted
Initial submission to the registry
October 9, 2017
CompletedFirst Posted
Study publicly available on registry
October 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2020
CompletedMarch 25, 2020
March 1, 2020
2.5 years
October 9, 2017
March 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Life Simple 7 (LS7) composite score
The "Life Simple 7" (LS7) Cardiovascular Health Index is a public health metric by the American Heart Association (AHA) and is an index of modifiable health behaviors and cardiometabolic risk factors. The LS7 includes three health factors (blood pressure, fasting glucose, total cholesterol) and four health behaviors (body mass index (BMI), physical activity, healthy diet and smoking) and classifies each of them as "ideal" (score of 2), "intermediate" (score of 1) and "poor" (score of 0) levels. Total scores range from 0 to 14 and total scores between 0-4 are classified as inadequate, scores between 5-9 are considered average, and scores between 10-14 are classified as optimum cardiovascular health.
Baseline, Month 6
Secondary Outcomes (9)
Change in Systolic Blood Pressure
Baseline, Month 6
Change in Diastolic Blood Pressure
Baseline, Month 6
Change in Delta Nutrition Intervention Research Initiative Food Frequency Questionnaire (Delta NIRI FFQ)
Baseline, Month 6
Change in Blood Glucose
Baseline, Month 3, Month 6
Change in Distance Walked Daily
Baseline, Month 3, Month 6
- +4 more secondary outcomes
Other Outcomes (11)
Change in High-sensitivity C-reactive Protein (HsCRP)
Baseline, Month 6
Change in Plasma Cysteine
Baseline, Month 6
Change in Cystine
Baseline, Month 6
- +8 more other outcomes
Study Arms (2)
Health360x
ACTIVE COMPARATORParticipants will use the Health360x application for 6 months.
Health360x plus health coach
EXPERIMENTALParticipants will use the Health360x application and received personalized health coaching for 6 months.
Interventions
Participants will view an orientation video which will include information on how to access the program from home and other internet access sites, how to use their activity monitor and sphygmomanometers, introduction to the curriculum, quizzes and discussion boards. Participants will be encouraged to upload their data at least once a week and to access the curriculum as often as desired. Technological and customer service support related to use of the application will be available 24 hours by phone.
Participants will be contacted by the health coach in the first week of the study to review their initial self-management behavioral goals and approaches. Follow up calls will occur each week for the first month, biweekly for the second and third months, and then once per month for the remainder of the study (months 4-6).
Eligibility Criteria
You may qualify if:
- Already participating in the Baseline Clinical Study
- Life Simple 7 (LS7) score of 8 or lower
- Internet access
- Self-reported ability to participate in physical activity
- English fluency
You may not qualify if:
- Coronary Artery Disease (CAD) documented by CAD diagnosis or prior acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass surgery, or chronic angina
- Aortic stenosis
- History of chronic diseases that may alter brachial artery flow-mediated vasodilation measurements, such as peripheral vascular disease, HIV/AIDS, lupus, or cancer
- Inability to participate in increased physical activity
- History of alcohol or drug abuse or psychiatric diagnosis that would interfere with ability to participate
- Women who are pregnant and/or breastfeeding
- Cognitive deficits severe enough to preclude participation or any medical or surgical problem that precludes meaningful participation
- Unwillingness to use the internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- American Heart Associationcollaborator
Study Sites (3)
Grady Health System
Atlanta, Georgia, 30303, United States
Morehouse School of Medicine, Clinical Research Center
Atlanta, Georgia, 30310, United States
Emory University Clinical Research Network
Atlanta, Georgia, 30322, United States
Related Publications (1)
Islam SJ, Kim JH, Topel M, Liu C, Ko YA, Mujahid MS, Sims M, Mubasher M, Ejaz K, Morgan-Billingslea J, Jones K, Waller EK, Jones D, Uppal K, Dunbar SB, Pemu P, Vaccarino V, Searles CD, Baltrus P, Lewis TT, Quyyumi AA, Taylor H. Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study. J Am Heart Assoc. 2020 May 5;9(9):e015247. doi: 10.1161/JAHA.119.015247. Epub 2020 Apr 28.
PMID: 32340530DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Arshed Quyyumi, MD
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 9, 2017
First Posted
October 13, 2017
Study Start
July 25, 2017
Primary Completion
January 30, 2020
Study Completion
January 30, 2020
Last Updated
March 25, 2020
Record last verified: 2020-03